---
$id: https://graph.org.ai/products/commodity/51351506
$type: Product
source: UNSPSC
code: "51351506"
title: "Haloprogesterone"
class: "51351500"
classTitle: "Estrogen, progestin, or internal contraceptive pregnanes"
family: "51350000"
familyTitle: "Estrogens and progestins and internal contraceptives"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Haloprogesterone

**UNSPSC Code**: 51351506
**Class**: [Estrogen, progestin, or internal contraceptive pregnanes](Estrogen, progestin, or internal contraceptive pregnanes.mdx)
**Family**: [Estrogens and progestins and internal contraceptives](../Estrogens and progestins and internal contraceptives.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic progestin with the molecular formula C21H28BrFO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 803BIX5JG5, chemically known as 17-bromo-6alpha-fluoropregn-4-ene-3,20-dione but generally known as haloprogesterone, which bears US NIH Compound Identifier 19056. European Medicines Agency schedules Haloprogesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08007MIG. The term HALOPROGESTERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). HALOPROGESTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule haloprogesterone under HS 29372300 and SITC 54153. As of Q4 2014, HALOPROGESTERONE remains the US FDA Preferred Term for this commodity. Haloprogesterone bears US NLM identifiers UMLS ID C2697562 and NCI Concept Code C74367. SMILES: BrC1(C2(C(C3C(C4(C(=CC(=O)CC4)C(F)C3)C)CC2)CC1)C)C(=O)C.

